INTASYL™ PH-762 self-delivering RNAi targeting PD-1 enhances the therapeutic efficacy of systemically administered HER2-targeted CAR-T cells in a SKOV3 model of human ovarian adenocarcinoma in NCG mice.
Molecular Therapy, 2021, Volume 29, Issue 4, Supplement 1. 10.1016/j.ymthe.2021.04.019. Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Brianna Rivest, James Cardia and Simon P. Fricker.